Offerings
Products
Distribution Products
- Mutual Funds
- Basket Investing
Services
- Demat Account
- 3 in 1 Account
Tools & Platforms
Platform
Tools & Calculators
- Open API
- Calculators
Pricing
SKY Learn

Sector: Pharmaceuticals & Biotechnology

Small Cap

Ind-Swift Laboratories Share Price

Q: What is the current share price of Ind-Swift Laboratories Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Ind-Swift Laboratories Ltd. is ₹ 139.9 on the NSE and ₹ 139.7 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

Q: What is the Market Capitalization of Ind-Swift Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Ind-Swift Laboratories Ltd. is approximately ₹ 1139.7 Cr.

Q: What are the PE and PB ratios for Ind-Swift Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Ind-Swift Laboratories Ltd. is 4.6, and the Price-to-Book (PB) ratio is 0.9.

Q: What is the 52-Week High and Low for Ind-Swift Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Ind-Swift Laboratories Ltd. shares was ₹ 151.98, and the lowest price was ₹ 68.72.

Q: Who are the major shareholders of Ind-Swift Laboratories Ltd.?

Significant shareholdings in Ind-Swift Laboratories Ltd. typically include entities such as: Promoter Public FII Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Ind-Swift Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Ind-Swift Laboratories Ltd. is often compared with other major players such as Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies and Sudeep Pharma for analysis and benchmarking.

Q: What is the latest dividend information for Ind-Swift Laboratories Ltd.?

Ind-Swift Laboratories Ltd. last declared a FINAL dividend of ₹ 1 per share for the financial period ending 2011. The record date was set as 2011-09-20, and the payment was/is scheduled around 2011-09-20. For the most current dividend announcements, refer to official company filings.

Ind-Swift Laboratories Ltd.

₹139.90

8.47(6.44%)

Trade Now

1st Apr 2026 | 11:57 AM

NSE : INDSWFTLAB

Open Free Demat Account

Ind-Swift Laboratories Performance

Price Movement

₹139.90

₹135.00

₹140.49

↘ Today's Low↗ Today's High

1 Year Performance

₹139.90

₹68.72

₹151.98

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹140.49

Low₹135.00

Open at₹135.00

Prev Close₹131.43

Volumes2.64 L

Avg Price₹139.03

Lower Circuit₹105.15

Upper Circuit₹157.71

Historical Performance

3M High₹151.98

3M Low₹87.15

1 Yr High₹151.98

1 Yr Low₹68.72

3 Yr High₹186.00

3 Yr Low₹55.10

5 Yr High₹186.00

5 Yr Low₹52.65

Ind-Swift Laboratories Fundamentals

Market Cap

Above industry Median

1,139.70 Cr.

PE Ratio (TTM)

Low in industry

4.60

Dividend Yield

Net Profit TTM

3.5% incr over last year

248.57

Net Profit Growth

3.5% incr over last year

248.57

PEG Ratio

High in industry

1.30

ROE

53% decr over last year

21.32

Operating Revenue TTM

594.47

Operating Revenue Growth

33.0% incr over last year

Book Value

Low in industry

0.90

MFI

MFI is mid-range

34.61

RSI

RSI is mid-range

44.98

EPS (TTM)

37.25

Debt to Equity

0.02

Face Value

Operating Profit Margin Qtr.

-3.02

Operating Profit Qtr.

4.18

Net Profit Qtr.

9.54

Operating Revenue Qtr.

150.85

PB Ratio

0.90

Ind-Swift Laboratories Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	149.48	150.44	147.99	144.75	1.41
Operating Expense	144.08	148.25	144.92	158.21	10.22
Operating Profit	5.40	2.19	3.07	-13.47	-8.81
Depreciation	8.84	6.98	6.68	7.44	0.25
Interest	0.67	2.01	1.15	-26.76	0.11
Tax	6.87	2.30	1.71	8.06	0
Net Profit	10.74	8.76	8.12	218.09	4.64

Ind-Swift Laboratories Technicals

Ind-Swift Laboratories Ltd. EMA & SMA

₹139.90

1.69 (1.22%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹136.4

Day EMA10 ₹138.1

Day EMA12 ₹138.4

Day EMA20 ₹138.3

Day EMA26 ₹137.2

Day EMA50 ₹130.6

Day EMA100 ₹120.5

Day EMA200 ₹112.3

Ind-Swift Laboratories Support and Resistance

Resistance

First Resistance₹135.83

Second Resistance₹140.22

Third Resistance₹142.89

Support

First Support₹128.77

Second Support₹126.10

Third Support₹121.71

Technical Indicators

Day RSI44.98

Day MFI34.61

Day ADX18.51

Day Commodity Channel Index-122.40

William-95.57

Day MACD1.23

Day MACD Signal Line2.93

Day ATR8.95

Day ROC12527.32

Day ROC21-10.73

Ind-Swift Laboratories Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	42	42	40.9	40.9	39.5	39.5
FII	0.6	0.5	3.1	4.3	14.8	14.3
DII	1	0.9	0.9	0.9	0.7	0.7
Public	56.4	56.6	55.1	53.9	45	45.5

Ind-Swift Laboratories Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	1.3 L	2.59 L	50.35%
Week	3.49 L	7.87 L	44.28%
1 Month	2.68 L	6.71 L	40.02%
6 Month	1.65 L	4.13 L	40.10%

Ind-Swift Laboratories SWOT Analysis

Strengths14

Weakness5

Opportunity0

Threats0

Strong Performer, Getting Expensive (DVM)

Companies with 10% increase in share price over three months, with rising net profit growth

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Year

Affordable Stocks with High ROE and Momentum

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Insiders bought stocks

Stocks Outperforming their Industry Price Change in the Quarter

Ind-Swift Laboratories Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Instrument Type
20 Sep, 2011	1	FINAL	Equity Share
16 Sep, 2010	1	FINAL	Equity Share
17 Sep, 2009	1	FINAL	Equity Share
18 Sep, 2008	1	FINAL	Equity Share
21 Sep, 2007	1	FINAL	Equity Share
22 Sep, 2006	1.5	FINAL	Equity Share
22 Sep, 2005	1.5	FINAL	Equity Share
23 Sep, 2004	1	FINAL	Equity Share

Ind-Swift Laboratories Stock Comparison

Financials	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Medistep Healthcare Ltd.	Influx Healthtech Ltd.
Price (₹)	₹5.54	₹99.90	₹101.40	₹114.80	₹16.50	₹214
% Change	4.92%	7.48%	1.59%	3.07%	0.00%	5.94%
Revenue TTM (₹ Cr)	₹83.60	-	₹282.74	-	-	-
Net Profit TTM (₹ Cr)	₹-34.95	-	₹15.30	-	-	-
PE TTM	-1.30	12.30	25.30	-	5.70	35.00
1 Year Return	428	-27.38	-20.79	22.4	-61.63	110.42
ROCE	-5.63	-	-	-	-	-

Similar Stocks

VENUSREM

Venus Remedies Ltd.

₹ 861.05

+5.00%

BALPHARMA

Bal Pharma Ltd.

₹ 65.00

+7.58%

HIKAL

Hikal Ltd.

₹ 160.67

+9.24%

NGLFINE

NGL Fine - Chem Ltd.

₹ 2139.70

+4.02%

HESTERBIO

Hester Biosciences Ltd.

₹ 1360.40

+8.05%

NATCAPSUQ

Natural Capsules Ltd.

₹ 154.49

+7.02%

KREBSBIO

Krebs Biochemicals & Industries Ltd.

₹ 43.00

+8.18%

KILITCH

Kilitch Drugs(I) Ltd.

₹ 137.00

+10.08%

SYNCOMF

Syncom Formulation (India) Ltd.

₹ 11.21

+8.83%

AAREYDRUGS

Aarey Drugs & Pharmaceuticals Ltd.

₹ 53.28

+4.99%

BIOFILCHEM

Biofil Chemicals & Pharmaceuticals Ltd.

₹ 27.35

+6.05%

AARTIDRUGS

Aarti Drugs Ltd.

₹ 347.00

+8.52%

WANBURY

Wanbury Ltd.

₹ 233.04

+5.00%

ORCHPHARMA

Orchid Pharma Ltd.

₹ 517.90

+7.35%

KOPRAN

Kopran Ltd.

₹ 119.21

+10.34%

IOLCP

IOL Chemicals and Pharmaceuticals Ltd.

₹ 78.40

+7.74%

ALBERTDAVD

Albert David Ltd.

₹ 620.00

+5.61%

GUFICBIO

Gufic BioSciences Ltd.

₹ 290.30

+6.03%

JAGSNPHARM

Jagsonpal Pharmaceuticals Ltd.

₹ 185.30

+0.69%

GUJTHEM

Gujarat Themis Biosyn Ltd.

₹ 245.67

+8.27%

UNICHEMLAB

Unichem Laboratories Ltd.

₹ 306.45

+4.43%

ANUHPHR

Anuh Pharma Ltd.

₹ 72.00

+7.46%

BLISSGVS

Bliss GVS Pharma Ltd.

₹ 229.36

+6.39%

MOREPENLAB

Morepen Laboratories Ltd.

₹ 37.14

+10.27%

FAQ's on INDSWFTLAB

What is the current share price of Ind-Swift Laboratories Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Ind-Swift Laboratories Ltd. is ₹ 139.9 on the NSE and ₹ 139.7 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Ind-Swift Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Ind-Swift Laboratories Ltd. is approximately ₹ 1139.7 Cr.

What are the PE and PB ratios for Ind-Swift Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Ind-Swift Laboratories Ltd. is 4.6, and the Price-to-Book (PB) ratio is 0.9.

What is the 52-Week High and Low for Ind-Swift Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Ind-Swift Laboratories Ltd. shares was ₹ 151.98, and the lowest price was ₹ 68.72.

Who are the major shareholders of Ind-Swift Laboratories Ltd.?

Significant shareholdings in Ind-Swift Laboratories Ltd. typically include entities such as:

Promoter
Public
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Ind-Swift Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Ind-Swift Laboratories Ltd. is often compared with other major players such as Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies and Sudeep Pharma for analysis and benchmarking.

What is the latest dividend information for Ind-Swift Laboratories Ltd.?

Ind-Swift Laboratories Ltd. last declared a FINAL dividend of ₹ 1 per share for the financial period ending 2011. The record date was set as 2011-09-20, and the payment was/is scheduled around 2011-09-20. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy